Biosurgery Market Size, Share Report, Analysis, Trends, Growth 2032

The global biosurgery market size and share revenue accrued earnings worth approximately USD 15893.67 Million in 2023 and is predicted to gain revenue of about USD 26,042.32 Million by 2032, is set to record a CAGR of nearly 5.64% over the period from 2024 to 2032.

Request Free Sample

Global Biosurgery Market: Overview

Biosurgery products are utilized in surgeries to lower post- and intra-operative complications. Different biological and synthetic products like soft tissue management, bone graft substitutes, surgical sealing agents, hemostatic agents, and anti-adhesive agents are used in the process of surgery to prevent excessive loss of blood and offer adhesion or tissue sealing and repair the damaged bones or tissues of the human body. Such advanced products improve the efficiency of physicians by allowing them to control the complications and difficulties in the complex surgical process.

Global Biosurgery Market: Growth Factors

The spike in the number of elective surgeries is one of the primary reasons for the growth of the global biosurgery market. Furthermore, the growing incidences of lifestyle disorders and chronic diseases will further complement the growth of the market. There is a significant shift in focus towards effective blood loss management during the surgeries, which in turn requires biosurgery products. The constantly growing geriatric population is the primary target requiring effective blood loss management. A large number of people suffer from traumatic injuries which will further drive the demand for biosurgery products as a replacement for ligature-based procedures. Manufacturers are increasing their funding to launch advanced and innovative biosurgery products in the market globally. Also, there is a rising concentration on boosting research and development activities to come up with various innovations in the field of biosurgery products.

Furthermore, manufacturers are expecting the research activities to bring some cost-effective biosurgical products that can expand their customer base globally. The post-pandemic landscape is likely to significantly boost the demand for biosurgical products manifolds because during the Covid-19 pandemic several elective surgical procedures were deprioritized. Therefore, it is expected that there will be a large number of elective surgical procedures in the forthcoming years. The growing marketing strategies adopted by manufacturers are likely to highly penetrate advanced surgical procedures in growing economies globally.

Request Free Sample

Biosurgery Market: Report Scope

Global Biosurgery Market: Segmentation

The global biosurgery market can be segmented into application, product, source, end-user, and region.

By application, the market can be segmented into gynecological, cardiovascular, neurological, general, orthopedic, and other surgeries. The neurological surgery segment accounts for the largest share in the global biosurgery market due to the wide number of applications of bone graft substitute products globally. However, the cardiovascular surgery segment is expected to be the fastest-growing segment during the forecast period due to the surging number of cardiac problems among people.

By product, the market can be segmented into staple line reinforcement, adhesion barriers, surgical sealants & adhesives, hemostatic agents, soft-tissue attachments, bone-graft substitutes, and others.

By source, the market can be segmented into synthetic and biologics products.

By end-user, the market can be segmented into clinics, hospitals, and others. The hospital segment holds the largest share in the global biosurgery market due to the constantly growing number of hospitals globally. Moreover, the high number of surgical procedures being performed in the hospital also supports the growth of the segment.

Global Biosurgery Market: Regional analysis

North America accounts for the largest share in the global biosurgery market due to the growing number of medical reimbursement policies in the region. Furthermore, the presence of key market companies in the region will accentuate the growth of the regional market manifolds.

Asia Pacific is likely to foresee a significant growth rate in forthcoming years due to the growing initiatives from the government to strengthen the medical infrastructure in the region. Furthermore, the growing disposable income of the people in the region is likely to encourage them to opt for elective surgeries, which in turn will also fuel the growth of the regional market.

Global Biosurgery Market: Competitive Players

Some of the significant players in the global biosurgery market are

• Vivostat A/S
• Stryker
• SIRAKOSS
• Ocular Therapeutix Inc.
• Integra LifeSciences
• Ethicon LLC.
• CryoLife Inc.
• BD
• Baxter
• B. Braun Melsungen AG
• Pfizer Inc.
• Cohera Medical Inc.
• Integra Lifesciences Holdings Corporation
• Agro Bio surgery Ltd
• and TELA BIO

Global Biosurgery Market: Segment Analysis

By Product Types

• Bone graft substitutes
• Surgical sealants
• Hemostatic agents
• Staple line reinforcement agents

By Applications

• Cardiovascular surgeries
• Gynecology surgeries
• Neurological surgeries
• Thoracic surgeries
• Urology surgeries
• Reconstructive surgeries

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market